Cite

MBD2 expression levels in patients with T2DM compared to control subjects: a) in all patients; b) in patients with newly-diagnosed T2DM; c) in patients with T2DM duration of less than 5 years; d) in patients with T2DM duration of more than 5 years.
MBD2 expression levels in patients with T2DM compared to control subjects: a) in all patients; b) in patients with newly-diagnosed T2DM; c) in patients with T2DM duration of less than 5 years; d) in patients with T2DM duration of more than 5 years.

Increase in the methylated fraction of BRCA1, CCND1, Prdx2, SCARA3 and Tp53 during the course of T2DM.
Increase in the methylated fraction of BRCA1, CCND1, Prdx2, SCARA3 and Tp53 during the course of T2DM.

Methylated (M) fraction of the analyzed genes in four DNA pools.

GenesControls M Fraction (%)Newly-Diagnosed T2DM M Fraction (%)T2DM Duration <5 Years M Fraction (%)T2DM Duration >5 Years M Fraction (%)
BRCA1 0.0 5.9 0.547.8
CCND1 0.013.614.734.1
Gadd45A 0.0 0.0 0.7 0.0
Gadd45G 0.0 4.9 4.8 0.0
GDF1598.598.497.795.9
Gpx3 1.423.613.1 9.5
Insig1 2.410.4 4.915.7
Prdx2 7.322.322.432.0
Rara 0.013.2 6.6 7.6
SCARA3 3.5 8.120.223.3
Tp53 0.0 5.9 6.410.2

Main characteristics (number, gender distribution, mean age, BMI, Hb A1c, diabetes duration, presence of MetS, arterial hypertension, chronic complications of diabetes of the participants in the subgroups according to diabetes duration: newly-diagnosed T2DM, T2DM duration of <5 years, and T2DM duration >5 years).

ParametersNewly-Diagnosed T2DMT2DM Duration <5 YearsT2DM Duration >5 Years
Number999
Sex6 males; 3 females5 males; 4 females5 males; 4 females
Age (years) (mean + SD)62.0 + 7.551.3 + 14.055.7 + 7.7
BMI (kg/m2)34.8 + 8.438.1 + 13.734.0 + 2.7
Hb A1c (%) 7.9 + 2.3 8.8 + 1.8 8.7 + 2.1
Duration (years) 0.0 2.2 + 0.8 6.8 + 1.9
MetS (%)7/9 (77.8)6/9 (66.7) 9/9 (100.0)
Arterial hypertension (%)6/9 (66.7)8/9 (88.9)8/9 (88.9)
Chronic complications of diabetes (%)2/9 (22.2)8/9 (88.9)8/9 (88.9)

List of 22 analyzed genes and the processes they mediate.

GenesProcesses Mediated by the Genes
Bnip3, Cyp1a1, Gpx3, Prdx2, Ptgs2 (Cox2)Oxidative stress
Atm, Brca1, Ccnd1, Gadd45a, Gadd45g, Mlh1, Msh2, Tp53DNA damage
Insig1, Ube2g2Unfolded protein response
Cstb, RaraHypoxia
Dnajc15Heat shock protein
Atm, Cdkn1a (P21cip1/Waf1), Gadd45a (Plab), Msh2, Tp53Growth arrest and senescence
Prdx2, Ptgs2 (Cox2)Inflammation
Bnip3, Cdkn1a (P21cip1/Waf1), Prdx2Anti-apoptosis
Brca1, Ccnd1, Cdkn1a (P21cip1/Waf1), Cyp1a1, Prdx2Proliferation and carcinogenesis
eISSN:
1311-0160
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Basic Medical Science, other